Genetic aberrations in glioblastoma multiforme: translocation of chromosome 10 in an O-2A-like cell line by Mao, X et al.
Recent studies have suggested that at least two distinct biological
lineages may give rise to glioblastoma multiforme (GBM; Noble
et al, 1995). By growing glioma-derived cells in tissue culture
conditions previously shown to promote in vivo-like development
of glial precursor cells, a human GBM cell line that is unambigu-
ously derived from cells of the human oligodendrocyte-type-2
astrocyte (O-2A) lineage has been isolated. Cells from this line
(termed Human O-2A/GlioBlastoma 1, or Hu-O-2A/Gb1) express
similar antigens, responsiveness to cytokines and small metabolite
profiles (as detected by 1H-nuclear magnetic spectroscopic
analysis) to primary O-2A progenitor cells isolated from optic
nerves of postnatal rats. In contrast, a second new GBM cell line,
designated IN1434, differs from both O-2A progenitor cells and
Hu-O-2A/Gb1 cells in most characteristics examined and appears
to be derived from an astrocytic lineage.
Consistent genetic aberrations found in GBM include deletion
or inactivation of the CDKN2 gene, amplification and/or over-
expression of genes such as EGFR, PDGFR and GLI, as well as
loss of heterozygosity (LOH) from chromosomes 13, 17 and 22
(Furnari et al, 1995). A critical step in the development of GBM
appears to be LOH of part or an entire homologue of chromosome
10, which occurs almost invariably in GBM but not in lower grade
tumors. Mutations have been found in GBM in two novel genes,
PTEN/MMAC1 at band 10q23.3 (Li et al, 1997; Steck et al, 1997)
and DMBT1 at 10q25.3–26.1 (Mollenhauer et al, 1997). However,
none of the other relevant genes on chromosome 10 have been
identified. In order to characterize some of the significant genetic
aberrations in GBM, and to determine whether GBMs of different
lineages have similar aberrations, we have conducted a detailed
genetic analysis of the cell lines Hu-O-2A/Gb1 and IN1434.
MATERIALS AND METHODS
Establishment of cell lines
Hu-O-2A/Gb1 was derived from a sporadic temporal GBM in a 59-
year-old male; IN1434 was derived from a sporadic frontal GBM in
a 70-year-old male. Both tumours were removed surgically before
treatment. The specimens were minced using crossed scalpels and
incubated in calcium and magnesium Dulbecco’s modified Eagle
medium–(DMEM–CMF) medium (ICRF) with 2000 units/ml colla-
genase (Sigma, UK) at 37°C for at least 1 h. For each tumour, parallel
cultures were set up with different conditions: DMEM supplemented
with 10% fetal calf serum (FCS) and 25 mg ml–1 of gentamicin, or
serum-free medium (DMEM–BS; Bottenstein and Sato, 1979)
mixed in a 50:50 ratio with astrocyte-conditioned medium (ACM).
ACM was prepared from growing purified rat cortical astrocytes in
DMEM–BS for 48 h (Noble and Murray, 1984; Noble et al, 1984).
Cultures were grown in humidified incubators in 5% carbon dioxide
at 37°C, and analysed with cell-type specific markers after two
passages of in vitro growth and at various subsequent passages up to
passage twenty.
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Immunohistochemical analysis
Cultures were analysed using monoclonal antibodies A2B5
(Eisenbarth et al, 1979), O1 and O4 (Sommer and Schachner,
1981), anti-galactocerebroside antibody (GalC; Ranscht et al,
1982) and anti-glial fibrillary acidic protein (GFAP; Bignami et al,
1972). A2B5 and O4 have been used previously to characterize rat
O-2A progenitor cells (Raff et al, 1983; Barnett et al, 1993). O1
and GalC antibodies specifically label oligodendrocytes, while
GFAP is a specific marker of astrocytes.
Cytogenetic analysis
The cell lines were harvested at passages 14–16 and metaphase
chromosomes prepared using standard techniques. Chromosome
aberrations were described according to ISCN (Mitelman, 1995).
A structural chromosome rearrangement or chromosome gain had
to be detected in at least two metaphase cells, and loss of a
chromosome in at least three such cells, to be defined as a clonal
aberration.
Fluorescence in situ hybridization
Fluorescence in situ hybridization (FISH) was performed on
metaphase spreads according to standard procedures (Senger et al,
1993) using probes shown in Table 1. Chromosome banding was
produced by staining with DAPI (diamidino-2-phenylindole-dihy-
drochloride 0.06 mg ml–1)/propidium iodide (0.5 mg ml–1) dissolved
in Cityfluor. Preparations were examined with a Zeiss Axioskop
microscope equipped with a cooled charged coupled device (CCD)
camera (Photometrics), and digitized images analysed using
SmartCapture software (Digital Scientific, Cambridge, UK). At
least 50 metaphase spreads and 100 interphase nuclei were
analysed for each experiment.
Microsatellite analysis
Microsatellite analysis of 74 loci derived from the Généthon set
(Gyapay et al, 1994) and covering all chromosomes, was
performed on the Hu-O-2A/Gb1 cell line only, as control lympho-
cytes were unavailable for IN1434. A subset of these loci is shown
in Table 2. All experiments were conducted ‘blind’. Forty
nanograms DNA from cells of passage 5 of Hu-O-2A/Gb1 and
control lymphocytes was amplified in 50 ml of reaction solution
containing 2.5 ml 1 ´ standard PCR buffer (Promega), 1.5 mM
magnesium chloride, 0.4 mM deoxynucleoside triphosphates
(dNTPs), 0.4 mM of each primer, and 0.5 u Taq polymerase. The
thermal cycling protocol was 94°C (4 min) ´ 1, 94°C/55°C (1 min
each) ´ 35, and 72°C (10 min) ´ 1. Products were electrophoresed
for 4 h on 8% non-denaturing polyacrylamide gels, and detected
by silver staining using standard methods. Allele loss was scored
by eye at informative loci if the intensity of one allelic band in the
Hu-O-2A/Gb1 was diminished in comparison with the other allele,
allowing for the relative intensity of the alleles in the lymphocyte
DNA. Novel alleles were scored as replication errors (RERs).
Protein truncation test
For mutation analysis of the DNA mismatch repair genes, total
mRNA was extracted from cells of passages 5 and 15 of Hu-O-
2A/Gb1 using the Quick Prep Micro kit (Pharmacia), and total
cDNA made using the First Strand kit (Pharmacia). Pairs of
Table 1 Probes used for FISH analysis
Probea Location Source (Ref.)
CHR...B Specific paints for Cambio
all chromosomes
Midi 1p36.1 E Volpi
pUC1.77 1cen HT Cooke and J Hindley
pA3.5 3cen HF Willard
Coatasome 5 5 paint Oncor
p4A16 5+9cen T Hulsebos
YN548 5q21 WF Bodmer
Coatasome 7 7 paint Oncor
p7E1 7cen EW Jabs
LIMK1 7q11.23 X Mao (Mao et al, 1997)
4.4 8 cen A Baldini
pM292 9 cen A Baldini
CDKN2 9p21.3–22.3 A Kamb
Cathepsin L 9q13 X Mao
cos50A5 9q13 S Chamberlain
AF10b 10p12 T Chaplin (Chaplin et al, 1995)
14A7b(D10S2103) 10p12.1 J Mao (Ma et al, 1996)
JC2139 (D10S637) 10p11.2 (50 cM) J Mao (Zheng et al, 1994)
6B2b (D10S1962) 10p11.2 J Mao (Ma et al, 1996)
JC2075 (D10S355) 10p11.2 (52 cM) J Mao (Zheng et al, 1994)
pA10RR8 10 cen P Devilee
sJRH-2b 10 cen E Volpi
FGF8 10q23 C Dickson
EIF5AP1 10q23.3 A Steinkasserer (Steinkasserer 
et al, 1995)
Oligoc 12 cen E Volpi
GLI/CHOP 12q13.3q14.1 R Anand
CDK4 12q14 R Anand
MDM2 12q14.3q15 R Anand
66G11 13 cen N Jankovsky
127B12d 13q12 N Jankovsky
104H12 13q12 N Jankovsky
43E12 13q13 N Jankovsky
47A12 13q14 N Jankovsky
97G2 13q14 N Jankovsky
98G5 13q21 N Jankovsky
170D10 13q22 N Jankovsky
87F7 13q32 N Jankovsky
47Q12 13q33 N Jankovsky
44BO6 13q34 N Jankovsky
54CO2 13q34 N Jankovsky
36CO5 13q34 N Jankovsky
pLC11A 11 + 14 cen HF Willard
cos11 14q24.2 D Bennett
pTRA 15 cen KH Choo
pSE16 16 cen HF Willard
CN2.3 16p13.1–13.3 H Durbin
CMAR 16q24.1 H Durbin
D20Z1 20 cen Cambio
AP2-g 20q13.2 H Hurst
p141/CH22 22 cen HF Willard
E289 22q11.1 P Scambler
C614 22q11.2 P Scambler
N14C6 22q11.2 P Scambler
N14A2 22q12.1 P Scambler
LIF 22q12.3 P Scambler
KI831 22q12.3 P Scambler
N78F11 22q13.1 P Scambler
N119A3 22q13.2 P Scambler
N14C3 22q13.2–13.3 P Scambler
N66C3 22q13.3 P Scambler
Coatasome X X paint Oncor
DXZ1 Xcen Oncor
YAC 8B7 Xq27.1 R Vatcheva
27D2 Xq28 R Vatcheva
aAll probes are cosmids except for chromosome paints, centromeres, and
probes designated YAC. bThe exact order of these probes on chromosome
10 is not known. cPrimers of PRINS. dAll the probes on chromosome 13 were
mapped during the course of this work.726 X Mao et al
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oligonucleotides were used to amplify specifically cDNA from the
hMSH2, hMLH1, hPMS2 and GTBP genes in two parts and the
hPMS1 gene in three parts (Liu et al, 1996). For the APC gene,
genomic DNA samples from passages 5 and 15 of Hu-O-2A/Gb1
and passage 16 of IN1434 were used as templates. Exon 15, which
comprises the greatest part of the coding region of the APC gene,
was amplified specifically in four parts. The protein truncation test
(PTT) was performed using standard procedures (van der Luijt et
al, 1997). Protein products were visualized by eye on the auto-
radiograph and their lengths compared with molecular weight
markers and samples of known wild-type genotypes.
RESULTS
Immunohistochemical phenotypes
Phenotypes were stable during the entire period tested, over 20
passages. Hu-O-2A/Gb1 cells grew in both sets of culture condi-
tions. In medium with FCS, approximately 80% of cells were posi-
tive for the astrocytic marker GFAP, but not for any of the other
markers tested. When the cells were grown in serum-free medium
with ACM, approximately 30–40% of cells were GFAP-positive
alone and up to 60% were O4-positive. Approximately 20–25%
of the O4-positive cells were also O1- and GalC-positive.
Approximately 1% of cells were A2B5-positive alone while 1–2%
were both GFAP- and A2B5-positive. Thus, the Hu-O-2A/Gb1
cultures contained the cell types that together comprise the O-2A
lineage.
IN1434 cells grew only in culture medium with FCS. Cells
expressed GFAP but did not react with A2B5, 04, 01 or GalC anti-
bodies, indicating that they were committed solely to astrocytic
differentiation. In addition, the metabolite composition of IN1434
cells did not resemble that of O-2A progenitor cells, as analysed by
proton nuclear magnetic resonance (1H-NMR) spectroscopy (M
Noble et al, unpublished observations). Therefore, all analyses
conducted thus far are most consistent with the view that Hu-O-
2A/Gb1 cells and IN1434 cells are derived from different glial
lineages.
Genetic aberrations
Hu-O-2A/Gb1
Cultures of Hu-O-2A/Gb1 grown in serum-free medium with
ACM were used for all subsequent studies. The chromosomes in
50 banded metaphase spreads were analysed and 11 karyotyped. A
chromosome number of 42–78, with a mode of 45, was present.
Clonal numerical aberrations were loss of chromosomes 6, 10, 13,
15, 16, 19 and 21, and gain of chromosomes 7 and 8. Every cell
had lost one homologue of chromosome 10, and the remaining
homologue had additional material on the short arm. Other struc-
tural aberrations include 14p+, del(5)(p15), and several markers
(Figure 1). Seventy-eight per cent of cells showed trisomy 7 and
22% showed tetrasomy 7. FISH and microsatellite analysis were
then used to characterize these aberrations in detail (see below).
Each of these approaches gave results that were consistent with
each other and with the cytogenetic analysis.
Translocation of chromosome 10
Nine microsatellite loci mapping to chromosome 10 (Table 2)
showed allele loss along the entire chromosome (Figure 2 A–C).
The sole chromosome 10 was translocated at band 10p11–12 to
chromosomes 15 and X (Figure 2 D–G, Figure 3). FISH showed
that probes AF10 and 14A7 (at 10p12) were translocated to a
derivative X chromosome at band Xq27–28, while probes 6B2,
JC2139, and JC2075 (at 10p11.23), and pA10RR8 (10cen), sJRH-
2b (10cen), FGF8 (10q23) and EIF5AP1 (10q23.3) remained on
the derivative chromosome 10. The region of chromosome 15
from band 15q11.2–15qter was shown by FISH to translocate to
band 10p11–12 of the derivative chromosome 10. Probe pTRA-20
(15cen) was absent from this chromosome. Probes YAC 8B7
(Xq27.1) and 27D2 (Xq28) were not present on the derivative X
chromosome or any other chromosome. The X chromosome paint
hybridized only to the derivative X chromosome. The region
Xq27-qter thus appears to be entirely lost from the genome.
dic(5;14)
In addition to an apparently normal homologue of chromosome 5
and a chromosome 5 with a deletion of band 5p15, most cells
(92%) contained a dicentric chromosome with material from bands
5pter–5q11–21 translocated onto the short arm of chromosome 14
(Figure 2H). Chromosome 5 material was not detected by FISH on
any other chromosome. Probe YN548 (5q21) was not present on
this chromosome. No mutation was detected in exon 15 of the
APC gene using the PTT (data not shown).
Table 2 Cytogenetic and genetic mapsa of selected microsatellite markers
used in analysis of Hu-O-2A/Gb1
Marker Cytogenetic Genetic(cM)
LOH at APC gene
D5S409 5q13q23 116
D5S421 5q13q23 129
D5S404 5q13q23 135
LOH in chromosome 10
D10S189 10p13 18
D10S211b 10p11.2 48
D10S197 10p11 53
D10S220 10q11q21 77
D10S210 10q21q22 95
D10S201 10q22 116
D10S192 10q23q24 142
D10S190 10q25q26 161
D10S186 10q26qter 180
LOH at MSH2 gene
D2S119 2p16 75
D2S391 2p16 81
D2S288 2p16 82
D2S123 2p16 85
LOH at MLH1 gene
D3S1561 3p23p21 59
D3S1277 3p23p21 60
D3S1611 3p23p21 60
D3S1612 3p23p21 60
RER status
D1S216 1p21 123
6D6S434 6q21q23 113
D8S255 8p11 69
D11S29 11q23 ?
D11S904 11p14p13 40
D11S1313 11p12 68
D11S901 11q12q13 94
D11S968 11q22 165
D17S787 17q24 83
D20S100 20q13 95
aMapping information from Whitehead Institute/MIT and Généthon. bMapping
from Trybus et al, 1996. LOH, loss of heterozygosity; RER, replication error.Genetic analysis of glioblastoma multiforme 727
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del(16)(p;q)
One apparently normal homologue of chromosome 16 was present
in every cell, as well as a homologue with both arms deleted
(Figure 2I). Probes CN2.3 (16p13.1–13.3) and CMAR (16q24.1)
were absent from this chromosome. Microsatellite analysis of
eight loci mapping to chromosome bands 16p13.3–q21 showed
retention of both alleles at each locus.
Other chromosomes
FISH analysis showed that 57% of cells had lost a copy of the
CDKN2 (p16) gene (9p21–22). FISH analysis using other probes
shown in Table 1 failed to detect any abnormalities. Analysis of
microsatellite loci (Table 2) in Hu-O-2A/Gb1 cells at passage 5
showed that the tumour was RER–. No allele loss occurred at
microsatellite markers close to the hMSH2 and hMLH1 genes.
11
23
7
5 4 1
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13 14 15 16 17 18
19 20 21 22 XY
Figure 1 G-banded karyotype of Hu-O-2A/Gb1. Arrows indicate chromosomes discussed in the text
A
B
C
D
E FG
H
Figure 2 (A–C) Microsatellite analysis of chromosome 10 in Hu-O-2A/Gb1. Left: tumour DNA. Right: normal DNA. (A) D10S189 (10pter–p13). (B) D10S210
(10q21–22). (C) D10S192 (10q23–24). (D–K) FISH analysis of Hu-O-2A/Gb1. (D) Probes pA10RR8 (10 cen, FITC) and CHR15B (15 paint, Texas red) on the
der(10) chromosome. (E) Coatasome X (X paint, FITC) and CHR10B (10 paint, Texas red) on the der(X) chromosome. (F) Cosmid 14A7 (10p12.1, Texas red)
and DXZI (X cen, FITC) on the der(X) chromosome. (G) YAC8B7 (Xq27.1, Texas red) and DXZ1 (X cen, FITC) on the der(X) chromosome. (H) CHR16B (16
paint, Texas red) on partial metaphase spread stained with DAPI, showing normal and deleted homologues of chromosome 16728 X Mao et al
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Subsequently, the PTT was used to search for truncating mutations
at loci hMSH2, hMLH1, hPMS1, hPMS2 and GTBP. All products
amplified from the mRNA of the tumour cells at passage 15 were
of wild-type length at these five loci. PTT analysis showed that
Hu-O-2A/Gb1 cells did not contain a truncated protein which
would indicate a nonsense or frameshift mutation. No abnormali-
ties were detected in the remaining microsatellite loci.
IN1434
Forty metaphase spreads had a chromosome number of 41–94,
with a modal chromosome number of 46 (Figure 4). Eighty-eight
per cent of cells were near-diploid cells and 12% were hyper-
diploid. Cytogenetic and FISH analysis revealed clonal gains of
chromosomes 5, 7, 18, 19 and 20, and clonal losses of chromo-
somes 6, 8, 10 and 22. FISH and microsatellite analysis were again
used to characterize these aberrations in detail, and gave consistent
results.
t(1;7)
Each cell had one normal chromosome 1 and a rearranged chro-
mosome 1 with chromosome 7 material translocated to both the
long and short arms (Figure 5 A–D). FISH analysis showed that
probe p7E1 (7cen) localized to the telomeric region of the long
arm of the rearranged chromosome 1. A cosmid probe for the
LIMK1 gene (7q11.23) was found on the telomeric regions of both
long and short arms of chromosome 1. This chromosome is thus
described as der(1)t(1;7)(p31;q11.23)/(q44;q11).
del(13)
One normal chromosome 13 and a rearranged chromosome 13
were present. Two-colour FISH was performed with 13 cosmid
probes covering the entire chromosome 13 (Figure 5 E–G).
Cosmids 127B12 (13q12), 43E12 (13q13), 47A12 and 97Q
(13q14) were found to be deleted from the rearranged chromo-
some, indicating an interstitial deletion.
Other loci
FISH analysis with all other probes listed in Table 1 showed
normal patterns. No APC mutation was detected using the PTT.
All other genomic regions tested appeared normal.
DISCUSSION
We have characterized genetic aberrations in two near-diploid
GBM cell lines of different cellular origins. The Hu-O-2A/Gb1
cells grown in serum-free medium with ACM express antigens and
have a differentiation potential and 1H-NMR profile characteristic
of the oligodendrocyte-type 2 astrocyte (O-2A) progenitor cell
lineage of the rat (Noble et al, 1995). IN1434 cells, in contrast,
appear to derive from a lineage committed solely to astrocytic
differentiation. Several cytogenetic aberrations in these lines have
been noted in other studies of GBM (Mitelman, 1994; Debiec-
Rychter et al, 1995). Of particular interest, however, are a translo-
cation of the sole copy of chromosome 10 in Hu-O-2A/Gb1
and a complex rearrangement involving chromosomes 1 and 7 in
IN1434.
Previous studies suggest the presence on chromosome 10 of
tumour suppressor genes besides PTEN/MMCA1 which are inacti-
vated during progression to GBM (Karlbom et al, 1993; Ichimura
et al, 1998). Both cell lines examined here had lost one homologue
of chromosome 10. The remaining homologue in Hu-O-2A/Gb1 is
translocated at band 10p11.2 to chromosomes 15 and X. The
rearrangement is defined as follows: 10pter–[AF10, 14A7] –
breakpoint – [JC2139, 6B2, JC2075] – cen. The AF10 gene which
is disrupted in acute leukemia (Chaplin et al, 1995) appears unaf-
fected in Hu-O-2A/Gb1. It is not yet clear whether genetic material
has been lost or a gene disrupted by this translocation. If so, the
cell line may be useful for cloning a tumour suppressor gene. The
same region also shows LOH in prostate cancer (Trybus et al,
1996).
The X;10 translocation in Hu-O-2A/Gb1 also results in deletion
of the region Xq27–qter from the genome. Although loss of an
15qter
10qter
10p11–12
15q11.2
Xpter
10p11–12
10qter
Xq27
15qter
15q11.2
der(15)
pTRA20 15cen
YAC8B7 Xq27
AF10
14A7
10p12
der(X) der(10)
FGF8
E15AP1
10q23
pA10R8
SJRH-2B 10cen
JC2139
6B2
JC2075
10p11.2
Figure 3 Diagram of translocations involving chromosome 10 in Hu-O-2A/Gb1. FISH results are shown on the derivative chromosomesGenetic analysis of glioblastoma multiforme729
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der(1)1 7 13del(13)
MARS
Figure 4  G-banded karyotype of IN1434. Arrows indicate chromosomes discussed in the text. Inset: partial karyotype showing chromosomes 1, der(1), 7, 13
and del(13)
A
B
C
D
G
F E
Figure 5(A–D) FISH analysis of the der(1) in IN1434. (A) G-banded der(1) chromosome and chromosome 7, showing regions of chromosome 7 translocated
to the der(1). (B) CHR1B (1 paint, rhodamine) and CHR7B (7 paint, FITC) showing translocation of chromosome 7 to 1p and 1q. (C) Cosmid LIMK1 (7q11.23,
rhodamine) hybridizing to both short and long arms of the der(1). (D) Probes p7E1 (7cen, FITC) and pUC1.77 (1 cen, rhodamine) showing 7 cen sequences at
the distal long arm region of the der(1). (E–G) FISH analysis of del(13) in IN1434. (E) CHR13B (13 paint, rhodamine) showing one smaller chromosome 13.
(F) Cosmids 66G11 (13cen, rhodamine) and 37Q12 (13q33, FITC) present on both homologues of chromosome 13. (G) Cosmids 127B12 (13q12, Texas red)
and 14A12 (13q14, FITC) present on the normal chromosome 13 but not on the del(13)entire sex chromosome is common in gliomas, we are unaware of
nullisomy for this region of the X chromosome being described
previously in GBM.
In Hu-O-2A/Gb1, a region of chromosome 5 from bands 5pter-
5q11–21 was translocated to the short arm of chromosome 14,
resulting in a dicentric chromosome. Two intact copies of chromo-
some 5 were also present. Most cases of Turcot’s syndrome, which
includes gastrointestinal tumours and GBM, result from germ-line
mutations of the APC tumour suppressor gene at band 5q21
(Hamilton et al, 1995). APC is therefore a prime candidate tumour
suppressor gene for GBM. Microsatellite analysis did not detect
allele loss at markers on chromosome 5, and no APC mutation was
detected by PTT. We have no evidence, therefore, that somatic APC
mutations were involved in the pathogenesis of Hu-O-2A/Gb1.
We tested Hu-O-2A/Gb1 cells for mutations of five DNA
mismatch repair (MMR) genes and for microsatellite instability,
since a subset of patients with Turcot’s syndrome have germ-line
MMR mutations. Neither MMR mutations nor microsatellite
instability were detected. Recently other studies failed to detect
microsatellite instability in gliomas (Amariglio et al, 1995; Ritland
et al, 1995), suggesting that the tumours of Turcot’s syndrome may
be unrepresentative of sporadic cases.
FISH analysis showed that 57% of Hu-O-2A/Gb1 cells had lost
one homologue of a cdk4 inhibitor, CDKN2A, which negatively
regulates cell cycle progression. Homozygous deletion, mutation
and loss of expression of the CDKN2 gene are among the most
common genetic aberrations in AA and GBM (Kamb et al, 1994;
Nobori et al, 1994).
Both Hu-O-2A/Gb1 and IN1434 had trisomy 7 in the majority
of cells and tetrasomy 7 in the remaining cells. Trisomy 7 is
another common aberration in gliomas. An investigation using
comparative genomic hybridization has found that gain of 7q in
particular is the most frequent event detected in adult low-grade
astrocytomas, suggesting that genes on 7q play an early role in
tumour development (Schröck et al, 1996). However, since
trisomy 7 is also found in non-neoplastic brain cells, its relevance
to glioma development is still debatable (Johansson et al, 1993).
No amplification of the EGFR gene (7p12) was found by FISH
analysis in Hu-O-2A/Gb1 or IN1434 (data not shown). However,
high expression of another gene on chromosome 7, LIMK1
(7q11.2), was observed in paraffin-embedded tumour tissue from
which Hu-O-2A/Gb1 was derived (Gutowski et al, in preparation).
Each cell in IN1434 had a complex rearrangement in which
chromosome 7 material, including the LIMK1 gene, was trans-
located to a derivative chromosome 1 at both the long and 
short arms. This rearrangement can be described as
der(1)t(1;7)(p31;q11.23)/(q44;q11). High expression of LIMK1
mRNA was also observed in this line (Gutowski et al, in prepara-
tion). The expression profiles of LIMK1 in the two cell lines are
consistent with a generally high expression of the gene in normal
brain tissue (Proschel et al, 1995).
Cytogenetic and FISH analysis showed that IN1434 had an
interstitial deletion of chromosome 13 involving bands 13q12–14.
These findings confirm previous studies showing deletion of chro-
mosome 13 in AA and GBM (Kim et al, 1995). The RB1 gene at
band 13q14 is a prime candidate target for the deletion, as it is
commonly mutated in astrocytic gliomas. Interestingly, mutation
of RB1 has been found to correlate inversely with mutations of the
CDKN2 gene in gliomas, confirming that perturbation of the cell
cycle regulatory pathway that includes RB1, CDKN2 and CDK4 is
a critical step in glioma development (Ueki et al, 1996).
The findings presented here raise intriguing questions
concerning the relationship between genetic aberrations and the
cellular lineages of tumors. Hu-O2A/Gb1 cells, which by a variety
of stringent biological criteria appear to be derived from oligo-
dendrocyte precursors, do not show the cytogenetic aberrations
characteristically observed in oligodendrogliomas or oligoastro-
cytomas such as LOH on 19q and 1p (Kraus, 1995), but rather
those seen with great frequencies in other GBMs. Moreover,
GBM-associated aberrations also were found in IN1434 cells that
appear to be derived from an astrocytic lineage. Answers to these
questions will require genetic studies on further gliomas which
have been unambiguously assigned to particular lineages.
The extent to which the O-2A lineage contributes to glioma
formation itself remains to be determined. However, reports that
such tumors frequently express sulfatide and/or GalC (Jennemann
et al, 1990; Singh et al 1994), and that some glioma-derived cell
lines can be induced to express GalC or mRNA for proteolipid
protein (Gillaspy et al, 1993; Kashima et al, 1993), are consistent
with the view that the Hu-O-2A/Gb1 cell line is not a unique
example of an O-2A tumour.
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